1
$\begingroup$

Cox regression seems useful as a broad strokes model for measuring survival/ churn of a subscription-based product/ account lifetime estimate -- and the broad factors that might influence the survival curve (and area under the curve for estimated lifespan).

Unlike typical human survival data however where there's generally a live/ die binary ---

In business terms, unlike with an account "dying" -- the living accounts can "grow" in terms of monthly/ annual revenue.

In other words, if one were building a model to predict "lifetime value" (estimated lifespan x (value per t ) .... would one combine a linear regression model to estimate "growth/ value" over time ... to combine with 'estimated lifespan remaining' essentially?

This seems like a fairly common business problem. I've been playing around with a few things -- and the Cox portion seems straightforward. In terms of estimating lifespan based on a few key variables & current age --

The other part seems complicated. Like sure, you can do a very basic 'any account that survives grows 10% per month" -- but in reality there are many measurable variables that would impact this prediction as well.

I suppose the models wouldn't be combined per se.... there would just be a Cox model for lifespan ... a regression model (or some sort of time series) -- for estimated 'Revenue per T' ... and then essentially a cross-product of some sort of the outputs...

$\endgroup$

1 Answer 1

0
$\begingroup$

easiest to use a discrete time survival model, aka any probabilistic classifier (eg logistic regression or xgboost) , which predicts probably of churn in next period, given didn't churn until then.

Then you can calculate any arbitrary payoff as the sum of probability of churning at each period x payoff at each period (for example)

$\endgroup$

Your Answer

By clicking “Post Your Answer”, you agree to our terms of service and acknowledge you have read our privacy policy.

Not the answer you're looking for? Browse other questions tagged or ask your own question.